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IN VITRO ANAPHYLAXIS IN GUINEA-PIG SKIN: AMPLIFICATION 
BY BURIMAMIDE 
SHOSO YAMAMOTO, M.D., DAVID FRANCIS, B.Se., AND MALCOLM W. GREAVES, M.D., PH.D., F.R.C.P. 
Institute of Dermatology, London, England 
The effects of burimamide, an H.-antihistamine, on the anaphylactic reaction in the sk in 
of ovalbumin-sensitized guinea pigs were studied in vitro. Burimamide enhanced the 
concentration of histamine in the supernatant fraction of antigen-challenged sensitized 
guinea-pig skin in a dose-related way, but did not alter the concentration of residual 
histamine in the sk in after antigen challenge. The enhanced histamine concentration in the 
supernatant was not due to increased histamine synthesis by the target cells during the 
reaction because the increase was not inhibited by a histid ine decarboxylase inhibi tor, 
Brocresine. In further experiments it was shown that guinea-pig skin possesses potent 
histamine degrading enzyme activity which is inhibited by burimamide. We suggest that 
inhibition of these degrading enzymes leads to the increase in histamine concentration in the 
presence of burimam ide. 
Some responses to histamine, including gastr ic 
acid secretion, increase in heart rate, and inhibition 
of myometrium, cannot be antagonized by 'conven-
tional antihistamines. Ash and Schild [1] proposed 
two classes of histamine receptors, H. and H •. 
Black and his colleagues [2] described a specific 
competitive H2 antagonist, burimamide, and sug-
gested that burimamide together with a conven-
tional (H I antagonist) antihistamine might prove a 
more effective combination in the management of 
whealing skin reactions due to histamine than 
either class of antihistamine alone . However the 
effect of H2 antagonists on anaphy laxis in sk in is 
unknown. We therefore report the effects of buri-
mamide on anaphylaxis in guinea-pig skin in vitro. 
MATERIALS AND METHODS 
The effect of burim amide on anaphylax is was studied 
using skin of ovalbumin-sensit ized guinea pigs by the 
method of Yeoh, Tay, and Greaves [3 ). 
Materials. Burimamide was a gift of Dr. Br imblecome 
(Smith, Kline and French Laboratories Ltd.). Brocresine 
(NSD 1055) and egg albumin (for sensitization) were 
obtained from Sm ith and Nephew Ltd., and British Drug 
Houses, respectively. 
Sensitization. Male guinea pigs weighing 200 to 300 gm 
were sensit ized by two subcutaneous inject ions of 0.5 ml 
egg albumin solu tion (1 %). T he sensitized gu inea pigs 
were used between 3 and 8 weeks later . 
Skin . Animals were killed by stunning followed by 
exsanguination. Shaved abdominal skin was sliced into 
500-/Lm-thick slices using a hand microtome. The slices 
were separated into a liquots of 4 or I) per tube (tota ling 70 
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mg wet weight approximately), the number per tube 
being constant in anyone experim ent. T he slices were 
washed 3 times in cold Tyrode solution prior to incuba-
t ion. 
Skin an.aphylaxis. Triplicate samples were used in all 
experiments. Anaphylaxis was obtained by incubating 
skin slices with ovalbumin antigen (5 x crystallized, 
Koch -Light Laboratories Ltd.) in concentrations of 10 
/Lg/ml for 15 min at 37°C. The reaction volume was 2 ml. 
The reaction was term inated by decantation of the 
supernatant Tyrode solution. Supernatant and residual 
histamine in each sample were expressed in absolu te 
amou nts. All histamine resul ts were expressed after 
subtraction of t he corresponding negat ive control va lues . 
Under these condi tions histamine release in positive 
control samples was approximately 50% of total hista-
mine in most experiments. The effect ofburimamide was 
studied by preincubating burimamide with t he skin slices 
for 5 m in at 37°C prior to challenge by ant igen (prein-
cubation volume 1 ml) , burimamide control samples 
being simi larly treated. 
Histamine assay. Histamine was measured by bioas-
say using the atropinized guinea-pig ileum preparation 
and an automatic bioassay apparatus. Histamine activ-
ity was estimated by comparison with contracti le re-
sponses to several concentrat ions of stand ard histamine 
solu t ions. That the smooth muscle contracting activity 
re leased from the skin was entirely due to histam ine was 
coni'irm ed using the specific antagonist mepyramine 
(10 - 6 M). Neither burimamide nor Brocresine interfered 
wit h the responses of t he gu inea-p ig ileum to histamine in 
the concentrations used. However, as an addit ional 
precaution, equal concentrations of the drugs were added 
to the standard histamine solu tions during bioassay . 
RESULTS 
Effect of Burimamide on Concentration of 
Histamine 
The concentration of histamine in the super-
natants of antigen-treated skin samples was higher 
in the presence of burimamide. In 8 experiments 
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burimamide in concentrations of 10-<l to 10- ' M 
caused a dose-related enhancement of the super-
natant histamine concentration in antigen-treated 
samples compared with positive control samples in 
which burimamide has been omitted (Tab. and 
Fig. 1). Burimamide did not significantly alter 
the residua l histam ine in antigen-challenged sam-
ples or the basal supernatant histamine concentra-
tion in negative control samples in the absence of 
antigen. The amount of histamine in the superna-
tants of unchallenged samples in the presence and 
absence of burimamide ranged from 0 to 34.3 and 
o to 26.0 ng, respectively. ' 
Effect of Histidine Decarboxylase Inhibitor 
The possibility that the higher histamine concen-
tration of the supernatants with burimamide was 
due to increased biosynthesis of histamine was 
considered. We therefore examined the effect of 
Brocresine on the increased histamine concentra-
tion in sa mples containing burimamide. Brocresine 
(4-bromo-3-hydroxybenzyloxyamine, NSD 1055) is 
an effective histidine deca rboxylase inhibitor in 
vitro [4,5 ]. Brocresine at a concentration of 10 - ' 
M (4 experiments) and 10 - 6 M (2 experiments) failed 
to prevent the increase in his tamine caused by 
burimamide. These results do not support the pos-
sibility that the increase in the histamine in the 
presence of antigen and burimamide is due to 
increased histamine synthesis. 
Enzymic Histamine Degradation: Inhib iton by 
Burimamide 
The alternative possibility was considered that 
guinea-pig skin contains histamine-degrading 
enzymes which normally cause decay of superna-
tant histamine during the period of incubation, and 
that burimamide inhibits this process. 
Skin slices (4 per tube) were incubated in the 
presence of 80 ng histamine (concentration 160 
ng/mi) for periods ranging up to 60 min. The 
results of one experiment are shown in Figure 2. 
TABLE. Amount of histamine released by ant igen in 
su.pernatant in the presence and absence 
of burimamide 
Each value represents the mean of t riplicate sam ples. 
Mean residua l hista mine ; 42 .4 ng ± 7.6 SEM (no 
burimamide) , 47.5 ng ± 9.3 SEM (10 - ' M burimam ide). 
Burim8micie (M) 
ExpL 
0 10 - ' 
1 27.7 65.6 
2 40.0 57.7 
3 46.3 77.0 
4 27.3 44.6 
5 97.7 148.0 
6 67.4 70.0 
7 53.3 143.7 
8 20.6 37 .7 
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FIG. 1. Effect of burimamide on concentration of his-
ta mine in supern atants of ant igen-challenged samples. n 
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FIG. 2. T im e-dependent histamine degradation dur-
ing incubation of histamine with guinea pig skin in 
Tyrode solu t ion at 37°C. Ordinate ; % reduction of 
ini tia l histam ine concentration (160 ng/ ml) in the pres-
ence of 4 s lices of gu inea-pig abdominal skin (wet we ight 
70 mg approx imately). No significant degrad ation 
occurred at 2°C. 
The histamine activity of the supernatant Tyrode 
solu tion declined progressively during incubation, 
15% of activity being lost at 15 min and 70% at 60 
min. The reduced activity was not due to absorp-
tion or uptake by the skin slices because t here was 
no increase in the histamine content of the sk in 
slices (determined by boiling for 10 min and 
bioassay after cooling). 
That the observed decay in histamine activity 
was enzym ic was supported by the temperature 
sensit ivity of the react ion. In two experiments, 4 
skin sli ces were incubated with 80 ng histam ine 
(concentration 160 ng/ml) for 60 min at 37°C and 
2°C. At 37°C histamine activity decayed by 71% 
but there was no significant reduction in histam ine 
activity after incubation at 2°C. 
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FIG. 3. Effect of burimamide on degradation of hista-
mine by gu inea-p ig skin, in two experiments . Ordinate = 
% degradation of histam ine activity in su pernatant. 
The effect of burimamide on degradation of 
histamine by guinea- pig skin was studied in two 
experiments. Skin slices (4 per tube) were incu-
bated with 80 ng histamine (concentration 160 
ng/rnl) at 37°C for 60 min in the presence of 
burirnamide (4 X 10- 6 to 4 x 10- 5 M) . The results 
given in Figure 3 show that burimamide caused a 
dose-related inhibition of histam ine degradation. 
DISCUSSION 
The present experiments have shown t hat buri-
rnamide amplifies the anaphylactic reaction in 
guinea-pig skin by reducing enzymic degradation 
of released histamine in vitro, thus leading to 
elevated concentrations of histam ine following 
challenge of sensitized skin by antigen . We were 
not able to detect evidence of enhancement of 
antigen-stimulated histamine release by burima-
rnide as suggested by Lichtenstein and Gillespie 
[6] a lthough the possibility of a small increase in 
release by burimamide cannot be excluded by our 
data. That t he increase of histam ine was not due to 
increased histamine formation was indicated by 
the fai lure of Brocresine, a histidine decarboxylase 
inhibitor, to reverse t he burimamide-induced in -
crease in histam ine. Although the concentrations 
we used are known to be effective in vitro (5 ), we 
cannot exclude the possibility that higher concen-
trations might have produced inhibition. 
T h e observation that gu inea-pig skin contains 
potent histamine-degrading enzyme activity was 
not unexpected. At least two types of histamine-
degrading enzymes have been identified . The prop-
erties and distribution of diamine oxidase and 
histamine-N-methyl transferase have long been 
recognized [7- 9). It has been shown that, in t he 
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guinea pig, methylation and oxidation of hista-
mine occurred to approximately the same extent 
(7). Brown and his colleagues compared hista-
mine-N-methyl transferase activity in severallabo-
ratory spec ies and found the highest level of 
activity in guinea-pig skin (9). It has been reported 
that histamine methylation is inhibited by buri -
mamide in guinea-pig atrium (10) and in pig 
gastric mucosa [ll). It is t herefore possible t hat, in 
the skin , histamine released from target cells 
during anaphylaxis might be inactivated by hista-
mine methylation and that burimam ide might 
reverse t his process. The molecular configuration 
of burimamide resembles that of histam ine. Both 
molecules are based on an imidazole ring, burima-
mide possessing a polymethyl- t hiourea substituent 
group . It seems probable t hat t he inhibitory action 
of burimamide on degradation of histamine is at-
tributable to substrate compet it ion. The slower 
rate of degradation of added histamine by skin 
(Fig. 2) compared with degradation of antigen-
evoked (endogenous) histamine (F ig. 1 and Tab.) 
is explained by t he greater accessibility of endoge-
nous histamine substrate to the degrad ing enzyme 
during secretion of histamine within the tissue. 
The inhibitory action of burim amide on histamine 
degradation was not seen in control samples con-
taining burimamide in t he absence of antigen in 
which low concentrations of histamine were pres-
ent due to "spontaneous" release of histamine 
during incubation. This can be explained by the 
extremely low "spontaneous" release of histamine 
during the 15-min period of incubation . 
Burimamide may prove to have a suppressive 
effect on h istamine-mediated inflammatory reac -
t ions in skin through an action on H 2 receptors of 
skin blood vessels [12 ). Nevertheless our ev idence 
raises t.he possibility that burimamide administra-
tion in vivo may amplify t he reaction through 
inhibition of histamine degradation in skin . Our 
results also suggest t hat enzymic degradation of 
histamine may have an important role in regula-
tion of skin anaphylaxis. 
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